Nature and extent of changes in the patient's information sheets of international multicentre clinical trials as requested by Spanish Research Ethics Committees
Tipo y magnitud de los cambios requeridos por los Comités Éticos de Investigación Clínica en las hojas de información para el paciente en los ensayos clínicos multicéntricos internacionales
Rafael Dal-Ré**
, Elena Morejón, Rafael Ortega
Autor para correspondencia
rafael.dal-re@gsk.com
Corresponding author: Dr. R. Dal-Ré.Medical Department. GlaxoSmithKline SA.Parque Tecnológico de Madrid.C/ Severo Ochoa, 2. 28760 Tres Cantos. Madrid. Spain
Corresponding author: Dr. R. Dal-Ré.Medical Department. GlaxoSmithKline SA.Parque Tecnológico de Madrid.C/ Severo Ochoa, 2. 28760 Tres Cantos. Madrid. Spain
Medical Department. GlaxoSmithKline SA. Tres Cantos. Madrid. Spain
Leído
909
Vecesse ha leído el artículo
571
Total PDF
338
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 0 | 2 | 2 |
| 2025 11 | 0 | 8 | 8 |
| 2025 10 | 0 | 10 | 10 |
| 2025 9 | 0 | 10 | 10 |
| 2025 8 | 0 | 19 | 19 |
| 2025 7 | 0 | 10 | 10 |
| 2025 6 | 0 | 13 | 13 |
| 2025 5 | 0 | 11 | 11 |
| 2025 4 | 0 | 4 | 4 |
| 2025 3 | 0 | 1 | 1 |
| 2025 2 | 0 | 7 | 7 |
| 2025 1 | 0 | 2 | 2 |
| 2024 12 | 0 | 8 | 8 |
| 2024 11 | 0 | 3 | 3 |
| 2024 10 | 0 | 3 | 3 |
| 2024 9 | 0 | 10 | 10 |
| 2024 8 | 0 | 5 | 5 |
| 2024 7 | 0 | 7 | 7 |
| 2024 6 | 0 | 11 | 11 |
| 2024 5 | 0 | 4 | 4 |
| 2024 4 | 0 | 19 | 19 |
| 2024 3 | 0 | 3 | 3 |
| 2024 2 | 0 | 8 | 8 |
| 2024 1 | 0 | 10 | 10 |
| 2023 12 | 0 | 9 | 9 |
| 2023 11 | 0 | 1 | 1 |
| 2023 10 | 0 | 8 | 8 |
| 2023 9 | 0 | 5 | 5 |
| 2023 8 | 0 | 8 | 8 |
| 2023 7 | 0 | 35 | 35 |
| 2023 6 | 0 | 3 | 3 |
| 2023 5 | 0 | 2 | 2 |
| 2023 4 | 0 | 3 | 3 |
| 2023 3 | 1 | 4 | 5 |
| 2023 2 | 0 | 8 | 8 |
| 2022 1 | 0 | 2 | 2 |
| 2022 12 | 0 | 4 | 4 |
| 2022 11 | 0 | 6 | 6 |
| 2022 10 | 0 | 6 | 6 |
| 2022 9 | 0 | 7 | 7 |
| 2022 8 | 0 | 9 | 9 |
| 2022 7 | 0 | 7 | 7 |
| 2022 6 | 0 | 6 | 6 |
| 2022 5 | 0 | 2 | 2 |
| 2022 4 | 0 | 11 | 11 |
| 2022 2 | 0 | 2 | 2 |
| 2021 1 | 0 | 1 | 1 |
| 2021 12 | 0 | 10 | 10 |
| 2021 8 | 0 | 9 | 9 |
| 2021 6 | 0 | 4 | 4 |
| 2021 4 | 0 | 4 | 4 |
| 2021 3 | 0 | 2 | 2 |
| 2021 2 | 0 | 4 | 4 |
| 2020 1 | 0 | 3 | 3 |
| 2020 12 | 0 | 2 | 2 |
| 2020 11 | 0 | 2 | 2 |
| 2020 10 | 0 | 1 | 1 |
| 2020 9 | 0 | 5 | 5 |
| 2020 8 | 0 | 1 | 1 |
| 2020 7 | 0 | 4 | 4 |
| 2020 6 | 0 | 1 | 1 |
| 2020 4 | 0 | 1 | 1 |
| 2020 3 | 0 | 4 | 4 |
| 2020 2 | 0 | 1 | 1 |
| 2020 1 | 0 | 6 | 6 |
| 2019 12 | 0 | 19 | 19 |
| 2019 11 | 0 | 1 | 1 |
| 2019 9 | 0 | 7 | 7 |
| 2019 7 | 0 | 10 | 10 |
| 2019 6 | 0 | 11 | 11 |
| 2019 5 | 0 | 13 | 13 |
| 2019 4 | 0 | 17 | 17 |
| 2019 3 | 0 | 1 | 1 |
| 2019 2 | 0 | 8 | 8 |
| 2018 12 | 0 | 5 | 5 |
| 2018 11 | 0 | 3 | 3 |
| 2018 10 | 0 | 8 | 8 |
| 2018 7 | 0 | 3 | 3 |
| 2018 6 | 0 | 1 | 1 |
| 2018 3 | 0 | 1 | 1 |
| 2018 1 | 0 | 1 | 1 |
| 2017 12 | 0 | 1 | 1 |
| 2017 10 | 4 | 1 | 5 |
| 2017 9 | 8 | 3 | 11 |
| 2017 8 | 6 | 5 | 11 |
| 2017 7 | 10 | 0 | 10 |
| 2017 6 | 17 | 3 | 20 |
| 2017 5 | 12 | 5 | 17 |
| 2017 4 | 8 | 23 | 31 |
| 2017 3 | 21 | 3 | 24 |
| 2017 2 | 21 | 1 | 22 |
| 2016 1 | 4 | 2 | 6 |
| 2016 12 | 32 | 5 | 37 |
| 2016 11 | 53 | 2 | 55 |
| 2016 10 | 82 | 2 | 84 |
| 2016 9 | 44 | 2 | 46 |
| 2016 8 | 10 | 2 | 12 |
| 2016 7 | 5 | 1 | 6 |
Mostrar todo
